My Pharma Reviews

Home
Archive
About
The Great Shift in Biotech R&D
In the new global triangle, China leads R&D, US preserves its high-margin market dominance, and India is the affordable-access engine. The triangle is…
 • 
Salil Kallianpur
“Doctor Ko Mat Milna, Bas Rate Batao?”
Is this the time to reimagine pharma selling in government institutions? More importantly, with govt seemingly discouraging pharma-HCP contact, is this…
 • 
Salil Kallianpur
1
Traditional Pharma is Ripe for Disruption
Brain Computer Interfaces (BCIs) are still years away from mass market or medical breakthroughs, but VCs now clearly believe that they are much more…
 • 
Salil Kallianpur

May 2025

Novartis scheme can be a partnership with a difference.
Local partnership for Sybrava is a golden opportunity for Novartis to create a partnership with a difference and reimagine medicine for India and…
 • 
Salil Kallianpur
3
Launch Excellence is a strong differentiator
Can generic products differentiate and win mindshare? Yes, even without clinical differentiation, commercial, emotional, and experiential…
 • 
Salil Kallianpur
1
Trump’s Executive Order to Reduce Prescription Drug Prices
Is this an attempt to reduce prices domestically, or is it partially motivated by the strategic need to counter China’s growing dominance in…
 • 
Salil Kallianpur
AI-Powered Personas and Digital Twins of Customers
To keep up with customer expectations on experience, pharma must move from guesswork to precision in its marketing, transforming customer insights from…
 • 
Salil Kallianpur
1
Pharma marketing is an oxymoron.
Is "pharma marketing" an oxymoron, like "happily married",“deafening silence”or “bitter sweet”?
 • 
Salil Kallianpur
1
Change is frightening
The phone wasn’t just a better telegraph—it was a new paradigm. Likewise, digital technology isn’t just a new channel; it’s a new way of doing business.
 • 
Salil Kallianpur
1

April 2025

© 2025 Salil Kallianpur
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture